Prescription of Monoclonal Antibodies Against Calcitonin Gene-Related Peptide for the Prophylaxis of Migraine in Austria: A Retrospective, Longitudinal Analysis of Nationwide Insurance Data. [PDF]
Zebenholzer K +4 more
europepmc +1 more source
Effectiveness and tolerability of lasmiditan in the acute treatment of migraine: a real-world, prospective, multicentric study (DART study). [PDF]
Vaghi G +28 more
europepmc +1 more source
Preliminary results of a withdrawal and detoxification therapeutic regimen in patients with probable chronic migraine and probable medication overuse headache [PDF]
core +1 more source
The Relevance of Crystal Clear and Unclear Days to Evaluate Residual Interictal Burden in Patients With Migraine Treated With CGRP Monoclonal Antibodies. [PDF]
Silvestro M +6 more
europepmc +1 more source
Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks: a randomised, double-blind, placebo-controlled study [PDF]
core +1 more source
Do patients with migraine and obesity receive different treatments? Insights from real-world data. [PDF]
Pardo K +3 more
europepmc +1 more source
Genetic Basis of the Negative Response to the Use of Triptans for the Treatment of Migraine-A Systematic Review and Meta-Analysis. [PDF]
Andreata VG +14 more
europepmc +1 more source
Pharmacist-led migraine consultations in community pharmacies: a pilot study of pharmacists' experiences and patient-reported outcomes. [PDF]
Holm LB +3 more
europepmc +1 more source
Advances of neuroimaging findings in medication overuse headache. [PDF]
Wang X +5 more
europepmc +1 more source

